Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Dermata Therapeutics Inc.

    NASDAQ: DRMA · Real-Time Price · USD
    0.69
    -0.01 (-1.43%)
    At close: Jun 17, 2025, 3:59 PM
    0.72
    3.43%
    After-hours: Jun 17, 2025, 06:19 PM EDT

    Dermata Therapeutics Statistics

    Share Statistics

    Dermata Therapeutics has 6.38M shares outstanding. The number of shares has increased by 1122.96% in one year.

    Shares Outstanding

    n/a
    		 6.38M

    Shares Change (YoY)

    n/a
    		 1122.96%

    Shares Change (QoQ)

    n/a
    		 166.11%

    Owned by Institutions (%)

    n/a
    		 38.16%

    Shares Floating

    n/a
    		 5M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,624

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 62.89K, so 0.99% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 62.89K

    Short % of Shares Out

    n/a
    		 0.99%

    Short % of Float

    n/a
    		 1.4%

    Short Ratio (days to cover)

    n/a
    		 1.34

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -0.69

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -0.19

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Dermata Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1.79

    Quick Ratio

    n/a
    		 1.79

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,535,932,625

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -72.69% in the last 52 weeks. The beta is 0.57, so Dermata Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.57

    52-Week Price Change

    n/a
    		 -72.69%

    50-Day Moving Average

    n/a
    		 0.78

    200-Day Moving Average

    n/a
    		 1.18

    Relative Strength Index (RSI)

    n/a
    		 38.68

    Average Volume (20 Days)

    n/a
    		 1,438,536

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -12.51B

    Net Income

    n/a
    		 -12.29B

    EBITDA

    n/a
    		 -12.29M

    EBIT

    n/a
    		 -12.29M

    Earnings Per Share (EPS)

    n/a
    		 -8032.22
    Full Income Statement

    Balance Sheet

    The company has 3.16M in cash and 0 in debt, giving a net cash position of 3.16M.

    Cash & Cash Equivalents

    n/a
    		 3.16M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -65.68M

    Total Assets

    n/a
    		 10.01M

    Working Capital

    n/a
    		 8.32M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -11.16M and capital expenditures 0, giving a free cash flow of -11.16M.

    Operating Cash Flow

    n/a
    		 -11.16M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -11.16M

    FCF Per Share

    n/a
    		 -7.3
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DRMA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for DRMA is $3, which is 322.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 322.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on May 16, 2024. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 May 16, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -11.32

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist